環亞國際醫療(01143.HK)總代價3,780萬元購元析代理權 配股支付
環亞國際醫療集團(01143.HK)公布,獨立第三方施明耀向公司間接全資附屬環亞國際輔助生殖科技集團,轉讓其在元析的代理協議中及就此享有的所有權利、義務、擁有權、權益及利益,代價為3,780萬元。
代價將以公司向施明耀配發2.3億股代價股份的方式償付,佔公司擴大後股本約19.9%,並成為公司主要股東。每股代價股份約0.164元,較該股昨日(18日)收市價0.177元折讓約7.3%。
根據代理協議,元析向施明耀授出獨家權利,於香港及澳門分銷一系列測試及測量產品,及向其授出非獨家權利,於內地以外亞洲地區(香港及澳門除外)分銷產品及售後服務。產品包括紫外分光光度計、可見光分光光度計、總有機碳分析儀及微波分解系統,廣泛用於環境、食品、化妝品、醫藥、生命科學及化學領域。
公司認為,轉讓為集團提供透過納入於中國擁有逾十年經驗且具規模之科學儀器生產商元析所生產測試及測量設備產品藉以擴展電子製造服務及分銷產品業務產品組合的良機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.